Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 14;11(11):CD008624.
doi: 10.1002/14651858.CD008624.pub3.

Interventions for drooling in children with cerebral palsy

Margaret Walshe  1 , Martine Smith, Lindsay Pennington
Affiliations

Interventions for drooling in children with cerebral palsy

Margaret Walshe et al. Cochrane Database Syst Rev. .

Abstract

Background: Drooling is a common problem for children with cerebral palsy (CP). This can be distressing for these children as well as for their parents and caregivers. The consequences of drooling include risk of social rejection, damp and soiled clothing, unpleasant odour, irritated chapped skin, mouth infections, dehydration, interference with speech, damage to books, communication aids, computers, and the risk of social isolation (Blasco 1992; Van der Burg 2006). A range of interventions exist that aim to reduce or eliminate drooling. There is a lack of consensus regarding which interventions are most effective for children with CP.

Objectives: (1) To evaluate the effectiveness and safety of interventions aimed at reducing or eliminating drooling in children with cerebral palsy. (2) To provide the best available evidence to inform clinical practice. (3) To assist with future research planning.

Search methods: We searched the following databases from inception to December 2010 : Cochrane Central Register of Controlled Trials (CENTRAL); Medline via Ovid; EMBASE; CINAHL; ERIC; Psych INFO; Web of Science; Web of Knowledge; AMED; SCOPUS; Dissertation Abstracts.We searched for ongoing clinical trials in the Clinical Trials web site (http://clinicaltrials.gov.) and in the Current Controlled Trials web site (http://www.controlled-trials.com/). We hand searched a range of relevant journals and conference proceeding abstracts.

Selection criteria: Only randomised controlled trials (RCTs) and controlled clinical trials (CCTs) were included.

Data collection and analysis: Data were extracted independently by MW, MS and LP and differences resolved through discussion.

Main results: Six studies were eligible for inclusion in the review. Four of these studies were trials using botulinum toxin-A (BoNT-A) and two were trials on the pharmacological interventions, benztropine and glycopyrrolate. No RCTs or CCTs were retrieved on surgery, physical, oro-motor and oro-sensory therapies, behavioural interventions, intra-oral appliances or acupuncture. In the studies eligible for review, there was considerable heterogeneity within and across interventions and a meta-analysis was not possible. A descriptive summary of each study is provided. All studies showed some statistically significant change for treatment groups up to 1 month post intervention. However, there were methodological flaws associated with all six studies.

Authors' conclusions: It was not possible to reach a conclusion on the effectiveness and safety of either BoNT-A or the pharmaceutical interventions, benztropine and glycopyrrolate. There is insufficient evidence to inform clinical practice on interventions for drooling in children with CP. Directions for future research are provided.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Alrefai 2009 {published data only}
    1. Alrefai A, Aburahma SK, Khader Y S. Treatment of sialorrhea in children with Cerebral Palsy: A double‐blind placebo controlled trial. Clinical Neurology and Neurosurgery 2009;111:79‐82. - PubMed
Camp‐Bruno 1989 {published data only}
    1. Camp‐Bruno JA, Winsberg BG, Green‐Parsons AP, Abrams JP. Efficacy of benztropine therapy for drooling. Developmental Medicine and Child Neurology 1989;31:309‐319. - PubMed
Jongerius 2004a {published data only}
    1. Jongerius PH, Hoogen FJA, Limbeek J, Gabreels FJ, Hulst K, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: A controlled clinical trial. Pediatrics 2004;114(3):620‐627. - PubMed
Lin 2008 {published data only}
    1. Lin YC, Sheh JY, Cheng ML, Yang PY. Botulinum toxin Type A for control of drooling in Asian patients with cerebral palsy. Neurology 2008;70:316‐318. - PubMed
Mier 2000 {published data only}
    1. Mier RJ, Bachrach S, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate. Archives of Pediatric and Adolescent Medicine 2000;154:1214‐1218. - PubMed
Reid 2008 {published and unpublished data}
    1. Reid SM, Johnstone BE, Westbury C, Rawicki B, Reddihough DS. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Developmental Medicine and Child Neurology 2008;50:123‐128. - PubMed

References to studies excluded from this review

Lewis 1994 {published data only}
    1. Lewis DW, Fontana C, Mehallick LK, Everett Y. Transdermal scopolamine for reduction of drooling in developmentally delayed children.. Developmental Medicine and Child Neurology 1994;36(6):484‐486. - PubMed
Mato 2010 {published data only}
    1. Mato A, Limeres J, Tomas I, Munos M, Abuin C, Feijoo J, Diz P. Management of drooling in disabled patients with scopolamine patches. British Journal of Clinical Pharmacology 2010;69:684‐688. - PMC - PubMed
Shionogi Pharma 1 {unpublished data only}
    1. Shionogi Pharma. Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children. Clinical Trials.Gov (NCT00173745) Unpublished.
Shionogi Pharma 2 {unpublished data only}
    1. Shionogi Pharma. Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition. Clinical Trials.gov (NCT00491894) Unpublished.

Additional references

Andretta 2005
    1. Andretta M, Tregnaghi A, Prosenikliev V, Staffieri A. Current opinions in sialolithiasis diagnosis and treatment. Acta Otorhinolaryngologica Italia 2005;25(3):145‐9. - PMC - PubMed
Bax 2005
    1. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N. Proposed definition and classification of cerebral palsy: April 2005. Developmental Medicine and Child Neurology 2005;47:571‐6. - PubMed
Beahm 2009
    1. Beahm D, Peleaz L, Nuss DW, Schaitkin B, Sedlmayr JC, Rivera‐Serrano CM, et al. Surgical approaches to the submandibular gland: a review of the literature. International Journal of Surgery 2009;7:503‐9. - PubMed
Berweck 2007
    1. Berweck S, Schroeder AS, Lee SH, Bigalke H, Heinen F. Secondary non‐response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands. Developmental Medicine and Child Neurology 2007;49:62‐4. - PubMed
Blasco 1992
    1. Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Developmental Medicine and Child Neurology 1992;34:849‐62. - PubMed
Brodsky 1993
    1. Brodsky L. Drooling in children. In: Arvedson JC, Brodsky L editor(s). Pediatric Swallowing and Feeding. San Diego CA: Singular Publishing, 1993:389‐416.
Burton 1991
    1. Burton MJ. The surgical management of drooling. Developmental Medicine and Child Neurology 1991;33:1110‐6. - PubMed
CONSORT 2010
    1. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. British Medical Journal 2010;340:698‐702.
Crysdale 2006
    1. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P. Saliva control issues in the neurologically challenged: A 30 year experience in team management. International Journal of Pediatric Otorhinolaryngology 2006;70:519‐27. - PubMed
El‐Hakim 2008
    1. El‐Hakim H, Richards S, Thevasagayam A. Major salivary duct clipping for control problems in developmentally challenged children. Archives of Otolaryngology ‐ Head and Neck Surgery 2008;134(5):470‐4. - PubMed
Faggella 1983
    1. Faggella RM, Osborn JM. Surgical correction of drool: a comparison of three groups of patients. Plastic and Reconstructive Surgery 1983;72:478‐83. - PubMed
Fairhurst 2010
    1. Fairhurst CBR, Cockerill H. Management of drooling in children. Archives of Disease in Childhood‐ Education and Practice Edition 2010;July:1‐6. [DOI: 10.1136/adc.2007.129478] - DOI - PubMed
Fischer‐Brandies 1987
    1. Fischer‐Brandies H, Avalle C, Limbrock GJ. Therapy of orofacial dysfunction in cerebral palsy according to Castillo‐Morales. European Journal of Orthodontics 1987;9:139‐45. - PubMed
Friedman 1974
    1. Friedman WH, Swerdlow RS, Pomarico JM. Tympanic neurectomy: a review and an additional indication for this procedure. Laryngoscope 1974;84:568‐77. - PubMed
Fuster Torres 2007
    1. Fuster Torres MA, Aytes LB, Escoda CG. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Medicina Oral Patologia Oral Y Cirugia Bucal 2007;12(7):E511‐7. - PubMed
Gainsborough 2008
    1. Gainsborough M, Surmo G, Maestri G, Colver A, Cans C. Validity and reliability of the guidelines of the surveillance of cerebral palsy in Europe for the classification of cerebral palsy. Developmental Medicine and Child Neurology 2008;50(11):828‐31. - PubMed
Glynn 2007
    1. Glynn F, O' Dwyer TP. Does the addition of sublingual gland excision to submandibular duct relocation give better overall results in drooling control?. Clinical Otolaryngology 2007;32:103‐7. - PubMed
Goode 1970
    1. Goode RL, Smith RA. The surgical management of sialorrhoea. Laryngoscope 1970;80:1079‐89. - PubMed
GRADE Working Group 2004
    1. GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328:1490‐1494. - PMC - PubMed
Harris 1980
    1. Harris MM, Dignam PE. A non‐surgical method of reducing drooling in cerebral‐palsied children. Developmental Medicine and Child Neurology 1980;22(3):293‐9. - PubMed
Hassin‐Baer 2005
    1. Hassin‐Baer S, Scheuer E, Buchman AS, Jacobson I. Botulinum toxin injections for children with excessive drooling. Journal of Child Neurology 2005;20(2):120‐3. - PubMed
Heine 1996
    1. Heine RG, Catto‐Smith AG, Reddihough DS. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Developmental Medicine and Child Neurology 1996;38(11):1030‐6. - PubMed
Heinen 2006
    1. Heinen F, Molenaers G, Fairhurst C, Carr L, Desloovere K, et al. European consensus table 2006 for botulinum toxin for children with cerebral palsy. European Journal of Paediatric Neurology 2006;10:215‐225. - PubMed
Heywood 2009
    1. Heywood RL, Cochrane LA, Hartley BE. Parotid duct ligation for treatment of drooling in children with neurological impairment. Journal of Laryngology and Otology 2009;123(9):997‐1001. - PubMed
Higgins 2008a
    1. Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): Wiley‐Blackwell, 2008:151‐185.
Higgins 2008b
    1. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): Wiley‐Blackwell, 2008:187‐241.
Johnson 2004
    1. Johnson HM, Reid SM, Hazard CJ, Lucas JO, Desai M, Reddihough DS. Effectiveness of the Innsbruck Sensori‐motor Activator and Regulator in improving saliva control in children with cerebral palsy. Developmental Medicine and Child Neurology 2004;46:39‐45. - PubMed
Jongerius 2003
    1. Jongerius PH, Thiel P, Limbeek J, Gabrieels FJM, Rotteveel JJ. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Archives of Disease in Childhood 2003;88:911‐4. - PMC - PubMed
Jongerius 2004b
    1. Jongerius PH, Rotteveel JJ, van Limbeek, Gabreels FJM, Hulst K, Hoogen FJH. Botulinum toxin effect in salivary flow rate in children with cerebral palsy. Neurology 2004;63:1371‐1375. - PubMed
Jongerius 2004c
    1. Jongerius P, Limbeek J, Rotteveel JJ. Assessment of salivary flow rate, biologic variation and measurement error. The Laryngoscope 2004;114(10):1801‐1804. - PubMed
Kauffman 2009
    1. Kauffman RM, Netterville JL, Burkey BB. Transoral excision of the submandibular gland: techniques and results of nine cases. The Laryngoscope 2009;113(3):502‐7. - PubMed
Kay 2006
    1. Kay S, Harchik AE, Luiselli JK. Elimination of drooling by an adolescent student with autism attending public high school. Journal of Positive Behavior Interventions 2006;8:24‐8.
Lanconi 1989
    1. Lancioni GE, Coninx F, Manders N, Driessen M. Use of automatic cueing to reduce drooling in two multihandicapped students. Journal of the Multihandicapped Person 1989;2:201‐10.
Lefebvre 2008
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley, 2008:95‐150.
McAloney 2005
    1. McAloney N, Kerawala CJ, Stassen LC. Management of drooling by transposition of the submandibular ducts and excision of the sublingual glands. Journal of Irish Dental Association 2005;51(3):126‐31. - PubMed
McCracken 1978
    1. Cracken A. Drool control and tongue thrust therapy for the mentally retarded. American Journal of Occupational Therapy 1978;32:79‐85. - PubMed
Mier 2000
    1. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhoea with glycopyrrolate. Archives of Pediatrics and Adolescent Medicine 2000;154:1214‐8. - PubMed
Nunn 2000
    1. Nunn J. Drooling: Review of the literature and proposals for management. Journal of Oral Rehabilitation 2000;27:735‐43. - PubMed
O' Dwyer 1997
    1. O' Dwyer T, Conlon B. The surgical management of drooling ‐ a 15 year follow‐up. Clinical Otolaryngology and Allied Sciences 1997;22(3):284‐7. - PubMed
Odding 2006
    1. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: Incidence, impairments and risk factors. Disability and Rehabilitation 2006;28(4):183‐191. - PubMed
Ong 2009
    1. Ong LC, Wong SW, Hamid HA. Treatment of drooling in children with cerebral palsy using ultrasound guided intraglandular injections of botulinum toxin A. Journal of Pediatric Neurology 2009;7(2):141‐145.
Palisano 2008
    1. Palisano RJ, Rosenbaum P, Bartlett D, Livingstone MH. Content validity of the expanded and revised Gross Motor Function Classification System. Developmental Medicine and Child Neurology 2008;50(10):744‐750. - PubMed
Poling 1978
    1. Poling A, Miller K, Nelson N, Ryan C. Reduction of undesired classroom behavior by systematically reinforcing the absence of such behavior. Education and Treatment of Children 1978;1:35‐41.
Puraviappan 2007
    1. Puraviappan P, Banarsi Dass D, Narayanan P. Efficacy of relocation of submandibular duct in cerebral palsy patients with drooling. Asian Journal of Surgery 2007;30(3):209‐15. - PubMed
Rapp 1980
    1. Rapp D. Drool control: long term follow‐up. Developmental Medicine and Child Neurology 1980;22:448‐453. - PubMed
Reddihough 2010
    1. Reddihough D, Erasmus CE, Johnson H, McKellar GMW, Jongerius PH. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: an international consensus statement. European Journal of Neurology 2010;17(2):109‐121. - PubMed
Reed 2009
    1. Reed J, Mans C, Brietzke S. Surgical management of drooling: a meta analysis. Archives of Otolaryngology ‐ Head and Neck Surgery 2009;135(9):924‐31. - PubMed
Reid 2010
    1. Reid SM, Johnson HM, Reddihough DS. The Drooling Impact Scale: A measure of the impact of drooling in children with developmental disabilities. Developmetal Medicine and Child Neurology 2010;52(2):e23‐e28. - PubMed
Scully 2009
    1. Scully C, Limeres J, Gleeson M, Tomas I, Diz P. Drooling. Journal of Oral Pathology and Medicine 2009;38:321‐7. - PubMed
Selley 1985
    1. Selley WG. Swallowing difficulties in stroke patients: A new treatment. Age Ageing 1985;14:361‐5. - PubMed
Senner 2004
    1. Senner JE, Logemann J, Zecker S, Gaebler‐Spira D. Drooling, saliva production, and swallowing in cerebral palsy. Developmental Medicine and Child Neurology 2004;46(12):801‐6. - PubMed
Tahmassebi 2003a
    1. Tahmassebi JF, Curzon MEJ. Prevalence of drooling in children with cerebral palsy attending special schools. Developmental Medicine and Child Neurology 2003;45(9):613‐7. - PubMed
Tahmassebi 2003b
    1. Tahmassebi JF, Curzon ME. The cause of drooling in children with cerebral palsy ‐ hypersalivation or swallowing deficit. International Journal of Paediatric Dentistry 2003;13(2):106‐11. - PubMed
Tan 2001
    1. Tan EK, Lo YL, Seah A, Auchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Journal of Neurological Sciences 2001;190:95‐7. - PubMed
Thomas‐Stonell 1988
    1. Thomas‐Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988;3:73‐78. - PubMed
Tintner 2005
    1. Tintner R, Gross R, Winzer UF, Smalky MD, Jankovic MD. Autonomic function after botulinum toxin type A or B. A double blind randomised trial. Neurology 2005;65:765‐7. - PubMed
Van De Heyning 1980
    1. Heyning PH, Marquet JF, Creten WL. Drooling in children with cerebral palsy. Acta‐rhino‐laryngologica Belgica 1980;34:691‐705. - PubMed
Van der Burg 2006
    1. Burg JJW, Jongerius PH, Limbeek J, Hulst K, Rotteveel JJ. Social interaction and self‐esteem of children with cerebral palsy after treatment of severe drooling. European Journal of Pediatrics 2006;165:37‐41. - PubMed
Van der Burg 2007
    1. Burg JJW, Didden R, Jongerius PH, Rotteveel JJ. Behavioral treatment of drooling: a methodological critique of the literature with clinical guidelines and suggestions for future research. Behavior Modification 2007;31(5):573‐94. - PubMed
Van der Burg 2009
    1. Burg JW, Didden R, Engbers N, Jongerius PH, Rotteveel JJ. Self‐management treatment of drooling: a case series. Journal of Behavior Therapy and Experimental Psychiatry 2009;43:106‐19. - PubMed
Walshe 2010
    1. Walshe M, Smith M, Pennington L. Interventions for drooling in children with cerebral palsy. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD008624] - DOI
Wilkie 1977
    1. Wilkie TF, Brody GS. The surgical treatment of drooling: a ten year review. Plastic and Reconstructive Surgery 1977;59(6):791‐7. - PubMed
Witherow 2008
    1. Witherow H, Lee N, George K, Marion M. The treatment of sialorrhoea/drooling using botulinum B toxin. British Journal of Oral and Maxillofacial Surgery 2008;46:e57.
Wong 2001
    1. Wong V, Sun JG, Wong W. Traditional Chinese medicine (tongue acupuncture) in children with drooling problems. Pediatric Neurology 2001;25(1):47‐54. - PubMed
Zeppetella 1999
    1. Zeppetella G. Scopolamine in the management of oral drooling: three case reports. Journal of Pain and Symptom Management 1999;17(4):293‐5. - PubMed

Publication types

MeSH terms